<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046200"><TermName>exatecan mesylate</TermName><TermPronunciation>(EK-suh-TEE-kan MEH-zih-layt)</TermPronunciation><TermDefinition><DefinitionText>An anticancer drug that is a type of topoisomerase inhibitor. Also called DX-8951f.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731436" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exatecan mesylate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731437" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exatecán mesilato&quot;" language="es" id="_4"/><SpanishTermName>exatecán mesilato</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento contra el cáncer que es un tipo de inhibidor de la topoisomerasa. También se llama DX-8951f.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-07-06</DateLastModified></GlossaryTerm>
